Skip to main content
. 2022 Aug 31;14(4):311–320. doi: 10.5114/jcb.2022.119451

Fig. 2.

Fig. 2

Relationship between dose of HR-CTV D90 and tumor diameter in each case. A) Relationship between HR-CTV D90 dose and tumor size at diagnosis. B) Relationship between HR-CTV D90 dose and tumor size during brachytherapy

3D-IGBT – three-dimensional image-guided brachytherapy; HBT – hybrid brachytherapy; PFS – progression-free survival